Canlyniadau Chwilio - Takeshi Shimamura
- Dangos 1 - 20 canlyniadau o 39
- Ewch i'r Dudalen Nesaf
-
1
Heat Shock Protein 90 Inhibition in Lung Cancer gan Takeshi Shimamura, Geoffrey I. Shapiro
Cyhoeddwyd 2008Revisão -
2
-
3
Interleukin‐13 receptor α2 chain gan Mitomu Kioi, Mariko Kawakami, Takeshi Shimamura, Syed R. Husain, Raj K. Puri
Cyhoeddwyd 2006Artigo -
4
Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas gan Masaaki Takamura, Michlle Sakamoto, Yoshinori Ino, Takeshi Shimamura, Takafumi Ichida, Hitoshi Asakura, Setsuo Hirohashi
Cyhoeddwyd 2003Artigo -
5
-
6
Proapoptotic BH3-Only BCL-2 Family Protein BIM Connects Death Signaling from Epidermal Growth Factor Receptor Inhibition to the Mitochondrion gan Jing Deng, Takeshi Shimamura, Samanthi A. Perera, Nicole E. Carlson, Dongpo Cai, Geoffrey I. Shapiro, Kwok‐Kin Wong, Anthony Letai
Cyhoeddwyd 2007Artigo -
7
Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells gan Britta Will, Tanya Siddiqi, Meritxell Alberich‐Jorda, Takeshi Shimamura, Katarina Luptakova, Philipp B. Staber, Daniel B. Costa, Ulrich Steidl, Daniel G. Tenen, Susumu Kobayashi
Cyhoeddwyd 2010Artigo -
8
Dependence on the MUC1-C Oncoprotein in Non–Small Cell Lung Cancer Cells gan Deepak Raina, Michio Kosugi, Rehan Ahmad, Govind Panchamoorthy, Hasan Rajabi, Maroof Alam, Takeshi Shimamura, Geoffrey I. Shapiro, Jeffrey G. Supko, Surender Kharbanda, Donald Küfe
Cyhoeddwyd 2011Artigo -
9
Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway gan Alexis B. Cortot, Claire E. Repellin, Takeshi Shimamura, Marzia Capelletti, Kreshnik Zejnullahu, Dalia Ercan, James G. Christensen, Kwok‐Kin Wong, Nathanael S. Gray, Pasi A. Jänne
Cyhoeddwyd 2012Artigo -
10
Chemokine (C-C Motif) Ligand 2 Mediates the Prometastatic Effect of Dysadherin in Human Breast Cancer Cells gan Jeong‐Seok Nam, Mi‐Jin Kang, Adam M. Suchar, Takeshi Shimamura, Ethan A. Kohn, Aleksandra M. Michalowska, V. Craig Jordan, Setsuo Hirohashi, Lalage M. Wakefield
Cyhoeddwyd 2006Artigo -
11
Transcriptional Profiling Identifies Cyclin D1 as a Critical Downstream Effector of Mutant Epidermal Growth Factor Receptor Signaling gan Susumu Kobayashi, Takeshi Shimamura, Stefano Monti, Ulrich Steidl, Christopher J. Hetherington, April M. Lowell, Todd R. Golub, Matthew Meyerson, Daniel G. Tenen, Geoffrey I. Shapiro, Balázs Halmos
Cyhoeddwyd 2006Artigo -
12
Combined EGFR/MET or EGFR/HSP90 Inhibition Is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET gan Lu Xu, Eiki Kikuchi, Chunxiao Xu, Hiromichi Ebi, Dalia Ercan, Katherine A. Cheng, Robert F. Padera, Jeffrey A. Engelman, Pasi A. Jänne, Geoffrey I. Shapiro, Takeshi Shimamura, Kwok‐Kin Wong
Cyhoeddwyd 2012Artigo -
13
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models gan D Li, Lauren Ambrogio, Takeshi Shimamura, Shigeto Kubo, Masaya Takahashi, Lucian R. Chirieac, Robert F. Padera, Geoffrey I. Shapiro, Anke Baum, Frank Himmelsbach, Wolfgang J. Rettig, Matthew Meyerson, Flavio Solca, Heidi Greulich, Kah Keng Wong
Cyhoeddwyd 2008Artigo -
14
Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[18F]-Fluoro-L-Thymidine ([18F]FLT) Positron Emission Tomography (PET) gan Roland T. Ullrich, Thomas Zander, Bernd Neumaier, Mirjam Koker, Takeshi Shimamura, Yannic Waerzeggers, Christa L. Borgman, Samir Tawadros, Hongfeng Li, Martin L. Sos, Heiko Backes, Geoffrey I. Shapiro, Jürgen Wolf, Andreas H. Jacobs, Roman K. Thomas, Alexandra Winkeler
Cyhoeddwyd 2008Artigo -
15
Intratumoral Heterogeneity in <i>EGFR</i>-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition gan Margaret Soucheray, Marzia Capelletti, Inés Pulido, Yanan Kuang, Cloud P. Paweletz, Jeffrey H. Becker, Eiki Kikuchi, Chunxiao Xu, Tarun B. Patel, Fátima Al‐Shahrour, Julián Carretero, Kwok‐Kin Wong, Pasi A. Jänne, Geoffrey I. Shapiro, Takeshi Shimamura
Cyhoeddwyd 2015Artigo -
16
PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data gan Elena Piñeiro-Yáñez, Miguel Reboiro‐Jato, Gonzalo Goméz-López, Javier Perales-Patón, Kevin Troulé, José Manuel Rodrı́guez, Héctor Tejero, Takeshi Shimamura, Pedro P. López‐Casas, Julián Carretero, Alfonso Valencia, Manuel Hidalgo, Daniel Glez‐Peña, Fátima Al‐Shahrour
Cyhoeddwyd 2018Artigo -
17
Somatic LKB1 Mutations Promote Cervical Cancer Progression gan Shana N. Wingo, Teresa D. Gallardo, Esra A. Akbay, Mei‐Chih Liang, Cristina M. Contreras, Todd Boren, Takeshi Shimamura, David S. Miller, Norman E. Sharpless, Nabeel Bardeesy, David J. Kwiatkowski, John O. Schorge, Kwok‐Kin Wong, Diego H. Castrillón
Cyhoeddwyd 2009Artigo -
18
Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer gan Takeshi Shimamura, Zhao Chen, Margaret Soucheray, Julián Carretero, Eiki Kikuchi, Jeremy H. Tchaicha, Yandi Gao, Katherine A. Cheng, Travis J. Cohoon, Jun Qi, Esra A. Akbay, Alec C. Kimmelman, Andrew L. Kung, James E. Bradner, Kwok‐Kin Wong
Cyhoeddwyd 2013Artigo -
19
LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma gan Wenjin Liu, Kimberly B. Monahan, Adam D. Pfefferle, Takeshi Shimamura, Jessica A. Sorrentino, Keefe T. Chan, David W. Roadcap, David W. Ollila, Nancy E. Thomas, Diego H. Castrillón, C. Ryan Miller, Charles M. Perou, Kwok‐Kin Wong, James E. Bear, Norman E. Sharpless
Cyhoeddwyd 2012Artigo -
20
HIF1α and HIF2α independently activate SRC to promote melanoma metastases gan Sara C. Hanna, Bhavani Krishnan, Sean T. Bailey, Stergios J. Moschos, Pei Fen Kuan, Takeshi Shimamura, Lukas D. Osborne, Marni B. Siegel, Lyn M. Duncan, E. Tim O’Brien, Richard Superfine, C. Ryan Miller, M. Celeste Simon, Kwok‐Kin Wong, William Y. Kim
Cyhoeddwyd 2013Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Cancer research
Biology
Cancer
Medicine
Gene
Internal medicine
Genetics
Biochemistry
Lung cancer
Epidermal growth factor receptor
Cell biology
Receptor
Erlotinib
Pathology
Signal transduction
Gefitinib
EGFR inhibitors
T790M
Kinase
Tyrosine kinase
Adenocarcinoma
Oncology
Immunology
Mutant
Tyrosine-kinase inhibitor
KRAS
Lung
Mutation
PI3K/AKT/mTOR pathway
Pharmacology